SEM1P1: A Potential Drug Target Or Biomarker for Various Diseases

Target Name: SEM1P1

NCBI ID: G153842

Other Name(s): SHFM1P1 | DSS1P1 | SEM1 pseudogene 1 | SHFM1P

SEM1P1: A Potential Drug Target Or Biomarker for Various Diseases

SEM1P1 (SHFM1P1) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 10 and encodes a protein known as SEM1P1.

SEM1P1 is a transmembrane protein that plays a role in the regulation of cell signaling pathways, specifically the TGF-β pathway. This pathway is involved in the development and maintenance of tissues and organs, as well as in the regulation of cell growth and differentiation. SEM1P1 is a key regulator of TGF-β activity, and studies have shown that it plays a critical role in the regulation of cell proliferation and survival.

In addition to its role in TGF-β signaling, SEM1P1 has also been shown to be involved in the regulation of other signaling pathways, including the PI3K/Akt signaling pathway. This pathway is involved in the regulation of cell survival and proliferation, and has been implicated in the development of various diseases, including cancer.

SEM1P1 has also been shown to be involved in the regulation of cell adhesion and migration. This is important for the development and maintenance of tissues and organs, and is also implicated in the development of various diseases, including cancer.

In conclusion, SEM1P1 is a gene that has the potential to be a drug target or biomarker for the treatment of various diseases. Further research is needed to fully understand its role in the regulation of cell signaling pathways and its potential as a therapeutic target.

Protein Name: SEM1 Pseudogene 1

More Common Targets